Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

1(17%)

Results Posted

100%(3 trials)

Terminated

1(17%)

Phase Distribution

Ph phase_2

17%

Ph not_applicable

33%

Ph phase_4

17%

Ph phase_1

17%

Ph phase_3

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

1(16.7%)

Phase 2Efficacy & side effects

1(16.7%)

Phase 3Large-scale testing

1(16.7%)

Phase 4Post-market surveillance

1(16.7%)

N/ANon-phased studies

2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(3)

Terminated(1)

Detailed Status

Completed3

Not yet recruiting1

Recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (16.7%)

Phase 21 (16.7%)

Phase 31 (16.7%)

Phase 41 (16.7%)

N/A2 (33.3%)

Trials by Status

not_yet_recruiting117%

recruiting117%

completed350%

terminated117%

Recent Activity

1 active trials

Showing 5 of 6

recruitingphase_4

Calfactant vs Poractant Alfa Using a Less Invasive Technique in Preterm Infants With Respiratory Distress Syndrome

NCT07350018

not_yet_recruitingphase_1

Little Lungs Study

NCT06855043

completedphase_2

CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients

NCT00999713

completednot_applicable

Self-dispersing Liquids as Aerosol Drug Carriers

NCT00628134

completednot_applicable

Comparison of Curosurf and Infasurf in the Treatment of Preterm Infants With Respiratory Distress Syndrome

NCT02834624

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT07350018Phase 4

Calfactant vs Poractant Alfa Using a Less Invasive Technique in Preterm Infants With Respiratory Distress Syndrome

Little Lungs Study

CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients

Completed

NCT00628134Not Applicable

Self-dispersing Liquids as Aerosol Drug Carriers

Completed

NCT02834624Not Applicable

Comparison of Curosurf and Infasurf in the Treatment of Preterm Infants With Respiratory Distress Syndrome

Completed

NCT00682500Phase 3

Calfactant for Direct Acute Respiratory Distress Syndrome

Terminated

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6